Insights

Cutting-Edge Gene Editing Prime Medicine, Inc. leverages Prime Editing technology to correct genetic mutations, offering a revolutionary approach to treating a wide range of genetic diseases. This advanced gene editing capability positions the company as a pioneer in the field and opens opportunities for collaborations and partnerships with organizations seeking innovative therapies.

Successful Financing Rounds With recent financing rounds totaling $300 million in investments, Prime Medicine, Inc. demonstrates strong financial backing and investor confidence in its gene editing technology and research. This financial stability not only ensures continuity in operations but also signifies growth potential, making the company an attractive prospect for strategic alliances and funding partnerships.

Expansion into Clinical Trials By launching clinical trials for genetic diseases such as autosomal recessive CGD, Prime Medicine, Inc. showcases its commitment to advancing novel therapies through rigorous testing and evaluation. This expansion into clinical research not only validates the efficacy of Prime Editing but also presents opportunities for pharmaceutical collaborations and licensing agreements based on successful trial outcomes.

Key Collaboration with Bristol Myers Squibb Through a strategic research collaboration and license agreement with Bristol Myers Squibb, Prime Medicine, Inc. gains access to resources for developing Prime edited ex vivo T-cell therapies and next-generation reagents. This partnership highlights the company's ability to forge key alliances with prominent industry players, paving the way for joint product development and market expansion opportunities.

Competitive Positioning and Market Differentiation Prime Medicine, Inc.'s focus on Prime Editing and gene therapy sets it apart from traditional pharmaceutical companies, offering unique treatment approaches for genetic disorders. This differentiation strengthens the company's competitive positioning in the biotechnology research sector, presenting opportunities for collaborations, licensing deals, and market penetration strategies driven by innovative therapies and technologies.

Similar companies to Prime Medicine, Inc.

Prime Medicine, Inc. Tech Stack

Prime Medicine, Inc. uses 8 technology products and services including SAS, Microsoft Excel, Oracle, and more. Explore Prime Medicine, Inc.'s tech stack below.

  • SAS
    Business Intelligence
  • Microsoft Excel
    Editors
  • Oracle
    Enterprise
  • Cisco
    Network Hardware
  • .NET
    Programming Languages
  • Smartsheet
    Project Management
  • Yoast SEO
    Search Engines
  • Google Tag Manager
    Tag Management

Media & News

Prime Medicine, Inc.'s Email Address Formats

Prime Medicine, Inc. uses at least 1 format(s):
Prime Medicine, Inc. Email FormatsExamplePercentage
FLast@primemedicine.comJDoe@primemedicine.com
89%
First.Last@primemedicine.comJohn.Doe@primemedicine.com
10%
Last_First@primemedicine.comDoe_John@primemedicine.com
1%

Frequently Asked Questions

Where is Prime Medicine, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s main headquarters is located at 60 First St Cambridge, Massachusetts 02141 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Prime Medicine, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Prime Medicine, Inc. is a publicly traded company; the company's stock symbol is PRME.

What is Prime Medicine, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s official website is primemedicine.com and has social profiles on LinkedIn.

How much revenue does Prime Medicine, Inc. generate?

Minus sign iconPlus sign icon
As of February 2025, Prime Medicine, Inc.'s annual revenue reached $35M.

What is Prime Medicine, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Prime Medicine, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2025, Prime Medicine, Inc. has approximately 260 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer: A. R.Chief Technical Officer: A. L.Chief Business Officer: R. B.. Explore Prime Medicine, Inc.'s employee directory with LeadIQ.

What industry does Prime Medicine, Inc. belong to?

Minus sign iconPlus sign icon
Prime Medicine, Inc. operates in the Biotechnology Research industry.

What technology does Prime Medicine, Inc. use?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s tech stack includes SASMicrosoft ExcelOracleCisco.NETSmartsheetYoast SEOGoogle Tag Manager.

What is Prime Medicine, Inc.'s email format?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s email format typically follows the pattern of . Find more Prime Medicine, Inc. email formats with LeadIQ.

How much funding has Prime Medicine, Inc. raised to date?

Minus sign iconPlus sign icon
As of February 2025, Prime Medicine, Inc. has raised $55M in funding. The last funding round occurred on Sep 30, 2024 for $55M.

When was Prime Medicine, Inc. founded?

Minus sign iconPlus sign icon
Prime Medicine, Inc. was founded in 2019.
Prime Medicine, Inc.

Prime Medicine, Inc.

Biotechnology ResearchMassachusetts, United States201-500 Employees

Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA.  A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations.  

We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients.  Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.

Section iconCompany Overview

Headquarters
60 First St Cambridge, Massachusetts 02141 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PRME
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $55M

    Prime Medicine, Inc. has raised a total of $55M of funding over 4 rounds. Their latest funding round was raised on Sep 30, 2024 in the amount of $55M.

  • $10M$50M

    Prime Medicine, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $55M

    Prime Medicine, Inc. has raised a total of $55M of funding over 4 rounds. Their latest funding round was raised on Sep 30, 2024 in the amount of $55M.

  • $10M$50M

    Prime Medicine, Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.